"Our new probiotic chewable tablet combines Lactobacillus casei 431 (L. casei 431) and vitamin C and is an ideal combination for immune support," said Charlotte Beyerholm, marketing manager, human health and nutrition.
L. casei 431 was originally isolated from infant faeces. The strain has been used since 1995 as an ingredient in food and food supplements with no reported side-effects.
It has been tested in clinical studies with subjects aged five months and upwards.